Anygen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 111

Employees

  • Stock Symbol
  • 196300

Stock Symbol

  • Share Price
  • $11.05
  • (As of Friday Closing)

Anygen General Information

Description

AnyGen Co Ltd is a bio-venture company. The Company manufactures peptide APIs and new drug development. It offers GMP peptides, Generic peptides, Custom peptides, Catalog peptides and other services.

Contact Information

Website
www.anygen.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Stock Exchange
KRX
Corporate Office
  • Gwangju Techno Park Test Production Building
  • Suite 206
  • Gwangju, 61008
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anygen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.05 $11.50 $6.15 - $17.83 $66.3M 6M 53.2K -$1.22

Anygen Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 71,906 71,906 36,784 74,184
Revenue 4,291 4,291 6,704 8,963
EBITDA (4,138) (4,138) (1,924) 1,943
Net Income (6,944) (6,944) (4,802) (1,475)
Total Assets 16,292 16,292 20,498 27,239
Total Debt 5,702 5,702 6,678 6,740
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anygen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anygen‘s full profile, request access.

Request a free trial

Anygen Patents

Anygen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022342994-A9 Composition for preventing or treating inflammatory bowel disease containing novel compound Pending 09-Sep-2021 000000000
AU-2022342994-A1 Composition for preventing or treating inflammatory bowel disease containing novel compound Pending 09-Sep-2021 000000000
CA-3219189-A1 Composition for preventing or treating inflammatory bowel disease containing novel compound Pending 09-Sep-2021 000000000
EP-4317171-A1 Composition for preventing or treating inflammatory bowel disease containing novel compound Pending 09-Sep-2021 000000000
AU-2022276988-A1 Antiviral composition comprising a nucleolin-binding peptide Pending 18-May-2021 A61K38/08
To view Anygen’s complete patent history, request access »

Anygen Executive Team (6)

Name Title Board Seat Contact Info
Jae Il. Kim Ph.D Chief Executive Officer & Board Member
Young Joon Kim Ph.D Board Member & Director of Research & Development
Ju Kim Executive Managing Director & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

Anygen Board Members (4)

Name Representing Role Since
Jae Il. Kim Ph.D Anygen Chief Executive Officer & Board Member 000 0000
Joo-yol Choi Hyundai Venture Investment Corporation Board Member 000 0000
Ju Kim Self Executive Managing Director & Board Member 000 0000
Young Joon Kim Ph.D Anygen Board Member & Director of Research & Development 000 0000
To view Anygen’s complete board members history, request access »

Anygen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anygen FAQs

  • When was Anygen founded?

    Anygen was founded in 2000.

  • Who is the CEO of Anygen?

    Jae Il. Kim Ph.D is the CEO of Anygen.

  • Where is Anygen headquartered?

    Anygen is headquartered in Gwangju, South Korea.

  • What is the size of Anygen?

    Anygen has 111 total employees.

  • What industry is Anygen in?

    Anygen’s primary industry is Biotechnology.

  • Is Anygen a private or public company?

    Anygen is a Public company.

  • What is Anygen’s stock symbol?

    The ticker symbol for Anygen is 196300.

  • What is the current stock price of Anygen?

    As of 12-Apr-2024 the stock price of Anygen is $11.05.

  • What is the current market cap of Anygen?

    The current market capitalization of Anygen is $66.3M.

  • What is Anygen’s current revenue?

    The trailing twelve month revenue for Anygen is $4.29M.

  • What is Anygen’s annual earnings per share (EPS)?

    Anygen’s EPS for 12 months was -$1.22.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »